Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian
A PowerWash Simulator sequel is exactly what we need right now
5/11/2025
Fruit, pistachio and matcha cakes : Philip Khoury’s loaf recipes
5/11/2025
The ‘pavement vigilante’ : why Cameron Roh is naming and shaming bad walking etiquette
5/11/2025
Share your views on the New York mayoral election results
5/11/2025
Other People’s Fun by Harriet Lane review – darkly comic tale of envy and revenge in the Insta age
5/11/2025
Camouflage clothing may be having a moment – but in our violent world, is that wise ? | Ellie Violet Bramley
5/11/2025